Gut Microbiota Composition Differs for Those With, Without Gestational Diabetes
By Lori Solomon HealthDay Reporter

TUESDAY, July 8, 2025 -- Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes, according to a study published online July 1 in Microbiology Spectrum.
Weirong Yao, from the Second Hospital of Zhangzhou in China, and colleagues analyzed the fecal microbiota of 61 pregnant women during the first trimester using 16S rRNA sequencing.
The researchers found that microbial profiles were correlated with oral glucose tolerance test results at 24 to 28 weeks of gestation and clinical delivery outcomes. Significant differences in gut microbiota composition between gestational diabetes mellitus and healthy pregnancies were seen for both the phylum and genus levels. An early diagnostic model based on genus-level markers achieved an area under the curve of 98.23, indicating high diagnostic precision.
"These findings suggest that microbiota-based tools could enable early, noninvasive detection of gestational diabetes mellitus, offering new opportunities for prevention and personalized management," the authors write. "This research highlights the role of the gut microbiome in pregnancy and has important implications for improving maternal and fetal health outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-09 06:00
Read more

- Psychedelics Can Help Cancer Patients Battling Depression
- FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo
- Weed Use Linked To Heart-Related Deaths
- CT Colonography Cost-Effective, Clinically Effective for CRC Screening
- Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence
- Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions